
Medico Remedies Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 73.97 Cr, PAT Rs 2.38 Cr
Updated: 9 Nov 2026 • 6:15 pm
Posted by:

Quick Answer
Medico Remedies Q2 Results FY27 were declared on 9 November 2026, with Standalone revenue of Rs 73.97 Cr, up 40.52% YoY from Rs 52.64 Cr, and net profit of Rs 2.38 Cr, down 7.39% from Rs 2.57 Cr. These quarterly results also show YoY growth in Operating Profit of 16.54% to Rs 3.17 Cr from Rs 2.72 Cr, so revenue and Operating Profit rose while net profit eased.
Medico Remedies Ltd (MEDICO) Q2 Results FY27 announced on 9 November 2026, covering the company's financial performance for the July to September quarter. The company reported Standalone revenue of Rs 73.97 Cr and PAT of Rs 2.38 Cr. The results date of 9 November 2026 anchors these standalone results, and Medico Remedies Q2 Results FY27 are analysed here using verified figures only.
This Medico Remedies Q2 Results results analysis covers the financial highlights, business drivers, outlook and risks, with Operating Profit and net profit set against revenue. Univest has arranged the results analysis in a fixed order so the numbers can be read quickly, starting with the financial highlights.
Click Here – Get Free Investment Predictions
Medico Remedies Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 73.97 Cr | Rs 52.64 Cr | +40.52% YoY |
| Operating Profit | Rs 3.17 Cr | Rs 2.72 Cr | +16.54% YoY |
| Net Profit (PAT) | Rs 2.38 Cr | Rs 2.57 Cr | -7.39% YoY |
Source: company filing for Medico Remedies Q2 Results FY27, 9 November 2026. Figures in Rs Crore, Standalone basis.
Key Takeaways from Medico Remedies Q2 Results: What Stands Out
- Revenue of Rs 73.97 Cr rose 40.52% YoY from Rs 52.64 Cr, which is the main YoY growth reading in Medico Remedies Q2 Results FY27.
- Operating Profit of Rs 3.17 Cr rose 16.54% YoY from Rs 2.72 Cr, so profit at the operating level grew more slowly than revenue.
- Net profit of Rs 2.38 Cr fell 7.39% YoY from Rs 2.57 Cr, which is the one headline line that moved against revenue.
- Net profit margin narrowed to 3.2% from 4.9% in the comparison quarter, which is a risk flagged in the quarterly data.
- Return on equity was 19.02% and return on capital employed was 23.28% in FY26, which leads into the performance analysis.
Medico Remedies Q2 Results FY27: Performance Analysis
Medico Remedies Q2 Results FY27 show revenue of Rs 73.97 Cr against Rs 52.64 Cr a year earlier, a YoY growth of 40.52%, while Operating Profit rose 16.54% to Rs 3.17 Cr. Net profit, however, eased 7.39% to Rs 2.38 Cr from Rs 2.57 Cr, so the quarterly results show revenue and net profit moving in opposite directions.
Operating Profit grew by less than revenue, and net profit slipped while sales rose, which is why the net profit margin of 3.2% sits below the 4.9% of the comparison quarter. This standalone results picture is the core of the Medico Remedies Q2 Results FY27 results analysis.
For this Medico Remedies Q2 Results results analysis, later quarterly results will show whether the YoY growth in revenue starts to carry through to net profit. That question leads to the business factors listed in the data.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth Year on Year – The business factors start with revenue, which grew 40.5% year on year to Rs 73.97 Cr in the latest quarter, the strongest supportive figure in Medico Remedies Q2 Results FY27 and a key part of the quarterly results.
Return on Equity at 19.02% – Return on equity was 19.02% in FY26, which describes the profitability earned on shareholders' funds over the last financial year and gives context for the latest quarter's earnings.
Return on Capital Employed at 23.28% – Return on capital employed was 23.28% in FY26, which describes the profit earned on the capital used in the business over the last financial year, alongside the equity return.
FY27 Outlook After Medico Remedies Q2 Results
The FY27 full-year picture will depend on the quarters still to be reported and on conditions disclosed by the company and its sector. This results analysis therefore treats the latest figures as one data point in FY27, and net profit will be the line to follow.
Within Medico Remedies Q2 Results FY27, revenue growth of 40.52% and a net profit decline of 7.39% set up the main comparison for later quarters. Readers can follow those filings on the Univest Screener and the Univest app, and the risks below are best monitored there.
Key Risks to Watch After Medico Remedies Q2 Results FY27
Net Profit Fell 7.4% YoY
Net profit fell 7.4% year on year to Rs 2.38 Cr even as revenue grew, so the direction of the bottom line is the first item to watch in later disclosures.
Net Profit Margin at 3.2%
Within Medico Remedies Q2 Results FY27, the net profit margin narrowed to 3.2% from 4.9% in the comparison quarter, so a smaller share of each rupee of revenue reached net profit than a year earlier.
Volatile Quarterly Net Profit
Quarterly net profit has been volatile, ranging from Rs 2.38 Cr to Rs 5.86 Cr over the last 5 quarters, so YoY growth in one line may not carry into the next quarter.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Medico Remedies Q2 Results FY27 show revenue growth of 40.52% YoY to Rs 73.97 Cr, Operating Profit up 16.54% to Rs 3.17 Cr and net profit down 7.39% to Rs 2.38 Cr. In summary, these quarterly results pair a strong top line with a lower bottom line. The wider read on Medico Remedies Q2 Results depends on how the standalone results develop in the quarters still to come. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Medico Remedies Q2 Results FY27
What are Medico Remedies Q2 Results FY27?
Ans. Medico Remedies Q2 Results FY27 cover the July to September 2026 quarter, with Standalone revenue of Rs 73.97 Cr and net profit of Rs 2.38 Cr, as set out in the Financial Highlights table of this article.
What is the results date for Medico Remedies Q2 Results FY27?
Ans. The results date for Medico Remedies Q2 Results FY27 is 9 November 2026, when the company declared its quarterly results, so every figure in the Financial Highlights table reflects that filing.
What revenue was reported in Medico Remedies Q2 Results FY27?
Ans. Medico Remedies reported revenue of Rs 73.97 Cr in the quarter, up from Rs 52.64 Cr a year earlier, which means the top line grew 40.52% as shown in the Performance Analysis.
What net profit was reported in Medico Remedies Q2 Results FY27?
Ans. Net profit in Medico Remedies Q2 Results FY27 was Rs 2.38 Cr, compared with Rs 2.57 Cr a year earlier, a fall of 7.39%, as the Performance Analysis section explains in detail.
How much YoY growth did revenue show in Medico Remedies Q2 Results FY27?
Ans. Revenue showed YoY growth of 40.52% in Medico Remedies Q2 Results FY27, rising to Rs 73.97 Cr, while Operating Profit grew 16.54%, as covered under Performance Analysis.
Did net profit rise or fall in Medico Remedies Q2 Results?
Ans. Net profit fell in Medico Remedies Q2 Results, down 7.39% to Rs 2.38 Cr from Rs 2.57 Cr, which means the bottom line moved against the direction of revenue growth.
What was the Operating Profit in Medico Remedies Q2 Results FY27?
Ans. Operating Profit in Medico Remedies Q2 Results FY27 was Rs 3.17 Cr, up 16.54% from Rs 2.72 Cr a year earlier, while net profit moved the other way, as the Key Takeaways section shows.
Are Medico Remedies Q2 Results consolidated results or standalone results?
Ans. Medico Remedies Q2 Results are standalone results, reported on a Standalone basis with revenue of Rs 73.97 Cr, so the figures in the Financial Highlights table are not consolidated numbers.
What business factors shaped Medico Remedies Q2 Results FY27?
Ans. The business factors in Medico Remedies Q2 Results FY27 include revenue growth of 40.5% year on year, return on equity of 19.02% and return on capital employed of 23.28% in FY26.
What are the key risks after Medico Remedies Q2 Results FY27?
Ans. The key risks after Medico Remedies Q2 Results FY27 are the 7.4% fall in net profit, the margin narrowing to 3.2% from 4.9%, and volatile quarterly net profit, as the Key Risks section sets out.
What is the outlook after Medico Remedies Q2 Results?
Ans. The FY27 outlook after Medico Remedies Q2 Results will depend on the quarters still to be reported, so this quarter is one data point, which the Outlook section treats alongside the net profit trend.
Where can I find the complete Medico Remedies Q2 Results FY27 data?
Ans. The complete Medico Remedies Q2 Results FY27 data sits in the Financial Highlights table above, and readers can also check the Univest Screener and the Univest app for later quarterly results.
Recent Articles

Voltas Share Price Slips About 3% After Voltas Q2 Results: Profit Rises 50% but One-Offs, Winter Demand and Two Opposite Broker Calls Frame the Debate
9 November 2026

Gujarat Energy Share Price Gains Nearly 2% as Profit Rises 26%: What the Gujarat Energy Q2 Results and the Brokerage View Show
9 November 2026

RM Drip and Sprinklers System Q2 Results FY27: PAT Falls 67.36% to Rs 1.87 Cr, Revenue Rs 28.95 Cr
9 November 2026

Highway Infra Share Price Rallies 47% in One Month, Inches Close to Its 52-Week High Before Highway Infra Q2 Results on 14 November 2026
9 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Voltas Share Price Slips About 3% After Voltas Q2 Results: Profit Rises 50% but One-Offs, Winter Demand and Two Opposite Broker Calls Frame the Debate
Gujarat Energy Share Price Gains Nearly 2% as Profit Rises 26%: What the Gujarat Energy Q2 Results and the Brokerage View Show
RM Drip and Sprinklers System Q2 Results FY27: PAT Falls 67.36% to Rs 1.87 Cr, Revenue Rs 28.95 Cr
Highway Infra Share Price Rallies 47% in One Month, Inches Close to Its 52-Week High Before Highway Infra Q2 Results on 14 November 2026
Emami vs Dabur Q2 Results: Which FMCG Giant Wins on Profit, Revenue and Dividend? A Metric-by-Metric Scorecard Without a Verdict
Popular this week
Enkei Wheels Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 345.37 Cr, PAT Rs 7.28 Cr

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





